Viewing StudyNCT00000859



Ignite Creation Date: 2024-05-05 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000859
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 1999-11-02

Brief Title: A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral AR Nucleoside Therapy in HIV-Infected Individuals With CD4 Cell Counts Less Than or Equal to 200mm3
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Viral Load View
HIV-1 View
Drug Resistance View
Drug Therapy Combination View
HIV Protease Inhibitors View
CD4 Lymphocyte Count View
Ritonavir View
Indinavir View
Disease Progression View
RNA Viral View
Genotype View
Nelfinavir View
Anti-HIV Agents View